4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-056794
Director sold 24,800 shares at an average $552.18 ($13,694,158)
- Director acquired 24,800 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRIEDMAN PAUL A Director | 2025-12-10 | Option exercise 10b5-1 | +24,800 | $15.80 | $391,840 | 211,964 | D |
| FRIEDMAN PAUL A Director | 2025-12-10 | Sale 10b5-1 | −624 | $547.75 | $341,794 | 211,340 | D |
| FRIEDMAN PAUL A Director | 2025-12-10 | Sale 10b5-1 | −535 | $548.51 | $293,451 | 210,805 | D |
| FRIEDMAN PAUL A Director | 2025-12-10 | Sale 10b5-1 | −409 | $549.99 | $224,945 | 210,396 | D |
| FRIEDMAN PAUL A Director | 2025-12-10 | Sale 10b5-1 | −4,316 | $550.93 | $2,377,826 | 206,080 | D |
| FRIEDMAN PAUL A Director | 2025-12-10 | Sale 10b5-1 | −7,193 | $551.67 | $3,968,129 | 198,887 | D |
| FRIEDMAN PAUL A Director | 2025-12-10 | Sale 10b5-1 | −5,533 | $552.74 | $3,058,332 | 193,354 | D |
| FRIEDMAN PAUL A Director | 2025-12-10 | Sale 10b5-1 | −5,001 | $553.83 | $2,769,728 | 188,353 | D |
| FRIEDMAN PAUL A Director | 2025-12-10 | Sale 10b5-1 | −1,029 | $555.00 | $571,091 | 187,324 | D |
| FRIEDMAN PAUL A Director | 2025-12-10 | Sale 10b5-1 | −160 | $555.39 | $88,862 | 187,164 | D |
| Derivatives | |||||||
| FRIEDMAN PAUL A Director | 2025-12-10 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −24,800 | 24,800 | D | ||
| Open-market sales · 24,800 sh · avg $552.18 · $13,694,158 | |||||||
Loading xslF345X05/wk-form4_1765575628.xml…